Campo Salvatore, Sardo Maria A, Trimarchi Giuseppe, Bonaiuto Michele, Castaldo Maria, Fontana Luisa, Bonaiuto Antonio, Bitto Alessandra, Saitta Carlo, Saitta Antonino
Department of Internal Medicine, University of Messina, Messina, Italy.
Clin Biochem. 2004 May;37(5):388-94. doi: 10.1016/j.clinbiochem.2003.12.012.
Increased plasma low-density lipoprotein-cholesterol (LDL-C) levels in hypercholesterolemic subjects are associated with enhanced LDL oxidation that represents an additional risk for atherosclerotic disease. Human serum paraoxonase (PON1), a high-density lipoprotein (HDL) associated enzyme, has been shown to protect LDL from oxidation, thus playing an important role in reducing the risk of atherosclerosis. PON1 gene polymorphisms have been found to be associated with the variations in serum PON1 levels and activities, and with the risk for coronary artery disease (CAD). This study was performed to evaluate the contribution of the PON1 promoter (-107)T>C and the coding region Gln 192 Arg (Q192R) and Leu 55 Met (L55M) polymorphisms to the presence of carotid atherosclerosis in 208 Sicilian subjects with primary hypercholesterolemia.
Carotid artery intima-media wall thickness (IMT) was measured as an indicator of early atherosclerotic disease. The subjects were classified according to whether they have a normal (<or=1 mm) or an abnormal (>1 mm) IMT. Subjects were also investigated for physical and biochemical parameters, including PON1 activity.
No significant differences were detected among the PON1 genotypes with respect to age, sex, BMI, plasma lipids, systolic blood pressure in both groups of patients. There were significant differences between PON1 genotypes with respect to PON1 activity. The 192QQ, 55MM and (-107)TT genotypes showed lower PON1 activity compared to the RR, LL and CC genotypes. The PON1 (-107)T>C genotype distribution in both IMT groups showed no significant differences in percentage of TT, CT and CC genotypes. Similar results were obtained analyzing the Q192R and L55M genotype frequencies. Stepwise forward logistic regression analysis confirmed the lack of association between PON1 genotypes and carotid abnormalities.
In conclusion, our data provided no evidence of a significant association between either PON1 promoter (-107)T>C or coding region, Q192R and L55M, polymorphisms and early carotid atherosclerosis in Sicilian hypercholesterolemic subjects.
高胆固醇血症患者血浆低密度脂蛋白胆固醇(LDL-C)水平升高与LDL氧化增强相关,而LDL氧化是动脉粥样硬化疾病的额外风险因素。人血清对氧磷酶(PON1)是一种与高密度脂蛋白(HDL)相关的酶,已被证明可保护LDL免于氧化,因此在降低动脉粥样硬化风险中发挥重要作用。已发现PON1基因多态性与血清PON1水平和活性的变化以及冠状动脉疾病(CAD)风险相关。本研究旨在评估PON1启动子(-107)T>C以及编码区Gln 192 Arg(Q192R)和Leu 55 Met(L55M)多态性对208名患有原发性高胆固醇血症的西西里受试者颈动脉粥样硬化存在情况的影响。
测量颈动脉内膜中层厚度(IMT)作为早期动脉粥样硬化疾病的指标。根据IMT是否正常(≤1mm)或异常(>1mm)对受试者进行分类。还对受试者的身体和生化参数进行了研究,包括PON1活性。
在两组患者中,PON1基因型在年龄、性别、BMI、血脂、收缩压方面均未检测到显著差异。PON1基因型在PON1活性方面存在显著差异。与RR、LL和CC基因型相比,192QQ、55MM和(-107)TT基因型的PON1活性较低。在两个IMT组中,PON1(-107)T>C基因型分布在TT、CT和CC基因型百分比方面无显著差异。分析Q192R和L55M基因型频率也获得了类似结果。逐步向前逻辑回归分析证实PON1基因型与颈动脉异常之间缺乏关联。
总之,我们的数据未提供证据表明PON1启动子(-107)T>C或编码区Q192R和L55M多态性与西西里高胆固醇血症受试者早期颈动脉粥样硬化之间存在显著关联。